ADELAIDE, AUS, Apr 19, 2022 - (ACN Newswire) - Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research Organization in APAC by Informa Pharma Intelligence.
Avance Clinical has undergone significant expansion in recent years, including new offices in Sydney and Melbourne to accommodate the growing clinical team in Australia.
The award winner will be announced on 1 September 2022. The finalists are: - Avance Clinical - Calyx - CMIC Group - EPS - ICON - Parexel - Syneos Health
Avance Clinical's CEO Yvonne Lungershausen said:
"Avance Clinical is extremely pleased to be selected as a finalist for this prestigious award. It is a credit to our amazing customer-focused team for delivering the CRO excellence that has been recognized by the Informa Pharma Intelligence award judges.
"Avance Clinical has a global reputation for agile clinical solutions to support accelerated clinical development for our international biotech clients. We are very proud of our growth and success in APAC in recent years."
According to Informa Pharma Intelligence:
This Award is to recognize CROs that provide full or specialist services to their clients and which have an office in either in Japan or the Asia region including Australia.
Judging considers the quality of services and relationships built with clients and pays particular attention to the innovative patient recruitment strategies the CRO has brought to the table.
The award is based on achievements in the 2021 calendar year.
Core areas judged include: - The particular capabilities and strengths the CRO offers - How the company has delivered results that exceed sponsor expectations - Innovations in patient recruitment strategy has the CRO brought to its partner - How it has improved its performance, for example, in its quality of data, timelines and transparency - The steps the company is taking towards streamlining data collection and reporting
Avance Clinical recently secured a significant investment from global private equity firm, The Riverside Company (Riverside), to support further regional and global expansion. The investment values the company in excess of $200m.
"With the support of Riverside and its powerful global footprint and deep healthcare experience, Avance Clinical will execute on its regional and international expansion plans organically and via acquisitions," said Lungershausen.
Avance Clinical is the Australian-owned CRO that provides global regulatory standard clinical research services across all phases to the local and international biopharma industry.
The company is also accredited as a gene technology CRO under the Office of the Gene Technology Regulator (OGTR) which has allowed it to expand into clinical trials for vaccines and GMO therapies.
"We have shown, with our high growth and industry-leading repeat business rates that our focus on gold standard technology paired with solution-orientated clinical experts is the mix our biopharma clients require in this fast-moving, competitive and high-stakes sector," said Lungershausen.
Avance Clinical has been recognised for the past two consecutive years with the prestigious Frost & Sullivan CRO Best Practices Award.
Avance Clinical is the largest premium full-service Australian CRO delivering quality clinical trials, with globally accepted data, in Australia and New Zealand for international biotechs. The company's clients are biotechs in their early phases of drug development that need fast, agile, and adaptive solution-oriented clinical research services.
Frost & Sullivan Awards Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient for the past two years, has been providing CRO services in the region for 24 years.
Pre-clinical through to Phase 1 and 2 Avance Clinical offers pre-clinical services with their experienced ClinicReady team right through to Phase 1 and 2 clinical services leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes.
With experience across more than 105 indications, the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review.
Technology Avance Clinical uses state-of-the-art technology and gold standard systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of the technology partners.
Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comAvance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research Organization in APAC by Informa Pharma Intelligence.
What happens when Binance decides to de-list a crypto asset? Will the chosen coin or token ever recover, or is the fall from grace enough to doom its prospects forever? We can study exactly this in real-time, as Binance recently delisted Hegic [HEGIC], renBTC [RENBTC], and sUSD [SUSD] on 11 April. In particular, HEGIC investors began to […]
Cryptocurrency adoption across the globe has been growing rapidly. Looking at the impressive market of digital tokens, several countries have been working on the regulations front- China being an exception. The opinion of lawmakers in this regard is of prime importance. Even so, the perception of a country’s citizens matters too. Well, on that note, […]
KUALA LUMPUR, Apr 13, 2022 - (ACN Newswire) - The 12th Global edition of World Cyber Security Summit aims to bring together global CISOs, Cyber Security leaders, investors, media outlets and government representatives all under one roof. Leading cyber security specialist agency, CyberSecurity Malaysia will join the Summit as the Supporting Partner.
World Cyber Security Summit - ASEAN, is set to take place on 12 April 2022 virtually. Dato' Ts. Dr Haji Amirudin Abdul Wahab; CEO, CyberSecurity Malaysia, will enlighten the attendees on 'New Danger of Digital Society: Why Cyber Security is so important today and what to be ready for tomorrow?'
- Strategic approach: How Governments are handling cyber security in a digital era. - Cyber Security and Smart Cities: advanced technologies for citizens' safety
"Cybersecurity becomes a major concern for many sectors and industries within a country. Its vulnerabilities are alarming and cyber-attack is beyond control. Furthermore, it is impossible to develop 100% cybersecurity approach. No matter how advanced cybersecurity implementation in one's country, perpetrators often find loopholes to attack. Hence, it is critical for a country to practice cyber resilient, understand potential risks and take effort to reduce them. Organisations within a country must be able to effectively respond to cyber-attack, bounce back and restore critical infrastructures to resume operations," said Dato' Ts. Dr Haji Amirudin Abdul Wahab, CEO of CyberSecurity Malaysia.
"Companies from ASEAN today are facing an increasingly competitive threat. Cyber-attacks and data breaches are sophisticated and personalized, putting ASEAN companies at greater risk of collapse. However, there are measures that they can leverage to protect themselves and ensure the safety of their organizations.," stated Mithun Shetty, CEO of Trescon,
About CyberSecurity Malaysia
CyberSecurity Malaysia is the national cybersecurity specialist and technical agency under the purview of the Ministry of Communications and Multimedia Malaysia (K-KOMM). In essence, CyberSecurity Malaysia is committed to provide a broad range of cybersecurity innovation-led services, programs, and initiatives to help reduce the vulnerability of digital systems, and at the same time strengthen Malaysia's self-reliance in cyberspace. Among specialized cyber security services provided are Cyber Security Responsive Services; Cyber Security Proactive Services; Outreach and Capacity Building; Strategic Study and Engagement, and Industry and Research Development. For more information, please visit http://www.cybersecurity.my.
About World Cyber Security Summit
World Cyber Security Summit is a thought-leadership-driven, business-focused, global series of events that takes place in strategic locations across the world.
The Summit is a one-of-a-kind gathering of pre-qualified CIOs, CEOs, CTOs, Heads of AI, Chief Digital Officers, Heads of Innovation and International Cyber Security experts.
Witness powerful keynotes, workshops, use-case presentations, product exhibitions, panel discussions and tech talks to find solutions for issues and trends within the Cyber Security and RPA space.
Trescon is a global business events and consulting firm that provide a wide range of business services to a diversified client base that includes corporations, governments and individuals. Trescon is specialized in producing highly focused B2B events that connect businesses with opportunities through conferences, road Summits, expos, demand generation, investor connect and consulting services.
For further details about the announcement, please contact: Jagriti Jaiswal, Corporate Communication, Trescon | email@example.com
Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comThe 12th Global edition of World Cyber Security Summit aims to bring together global CISOs, Cyber Security leaders, investors, media outlets and government representatives all under one roof.
Blockchain technology and the vivid range of products and services built upon it are touted as the “key drivers” of the next wave of innovation across the traditional and digital ecosystems. The transition from Web2 to Web3 is happening faster than ever, as is evident from the growing popularity of blockchain-native applications. In the last […]
The Moroccan central bank is currently holding talks with multilateral lending institutions and other central banks, centered on establishing cryptocurrency regulation best practices.
Inevitable Adoption of Cryptocurrencies
The Moroccan central bank governor, Abdul Latif Al Jawhari, has said his institution is currently in discussion with the International Monetary Fund (IMF) and the World […]
A top executive at investment management behemoth BlackRock says the company is researching crypto assets in response to heightened interest from clients. In a new letter, CEO and co-founder Larry Fink says that digital assets can resolve many of the problems associated with international payments, such as high prices and associated crimes. “A global digital […]